Polymer protection for vaccines and drugs Science and Technology of Advanced Materials Dec 09, 2022 23:00 HKT/SGT Read More
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing Legend Capital Dec 09, 2022 19:27 HKT/SGT Read More
NLS Pharmaceutics、BVF Partners L.P.から最大3,000万ドル資金調達 NLS Pharmaceutics Ltd. Dec 08, 2022 08:00 JST Read More
Novotech 荣获 2022 年亚太地区 CRO 临床试验最佳实践奖 Novotech Health Holdings Pte Ltd Dec 07, 2022 06:00 HKT/SGT Read More
Novotech 榮獲 2022 年亞太地區 CRO 臨床試驗最佳實踐獎 Novotech Health Holdings Pte Ltd Dec 07, 2022 06:00 HKT/SGT Read More
노보텍, 임상 시험 모범 사례로 2022년 아시아 태평양 CRO 상 수상 Novotech Health Holdings Pte Ltd Dec 07, 2022 06:00 HKT/SGT Read More
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing A*STAR Dec 06, 2022 15:00 JST Read More
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing A*STAR Dec 06, 2022 14:00 HKT/SGT Read More
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials Novotech Health Holdings Pte Ltd Dec 06, 2022 11:00 HKT/SGT Read More
Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium Eisai Dec 01, 2022 19:09 HKT/SGT Read More
Prenetics公布一项2,000万美元股份回购计划及获纳入MSCI全球微型股指数 Prenetics Global Limited Nov 30, 2022 22:45 HKT/SGT Read More
Prenetics公布一項2,000萬美元股份回購計劃及獲納入MSCI全球微型股指數 Prenetics Global Limited Nov 30, 2022 22:44 HKT/SGT Read More
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index Prenetics Global Limited Nov 30, 2022 22:43 HKT/SGT Read More
エーザイ、抗アミロイドβプロトフィブリル抗体「レカネマブ」の早期アルツハイマー病に対する臨床第III相Clarity AD検証試験結果を第15回アルツハイマー病臨床試験会議(CTAD)において発表 Eisai Nov 30, 2022 17:30 JST Read More
エーザイ、11名の先端医療機関の専門家および8名のエーザイ研究者による「レカネマブ」の早期アルツハイマー病に対する臨床第III相Clarity AD検証試験結果の論文がthe New England Journal of Medicineに掲載 Eisai Nov 30, 2022 17:30 JST Read More
Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease at Clinical Trials on Alzheimer's Disease (CTAD) Conference Eisai Nov 30, 2022 09:21 HKT/SGT Read More
Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine Eisai Nov 30, 2022 08:31 HKT/SGT Read More
Eisai Announces Approval of Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Eisai Nov 29, 2022 18:28 HKT/SGT Read More